Contact Us
Drug Search Results
More Filters [+]

Riferminogene pecaplasmid

Alternative Names: riferminogene pecaplasmid, XRP-0038, XRP0038, XRP 0038
Latest Update: 2017-06-08
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Angiogenesis Activator

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Riferminogene pecaplasmid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Peripheral Vascular Diseases|Peripheral Arterial Disease

Phase 2: Peripheral Vascular Diseases|Arterial Occlusive Diseases|Peripheral Arterial Disease|Intermittent Claudication

Phase 1: Peripheral Arterial Disease|Arterial Occlusive Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2006-006277-24

P3

Completed

Unknown

2012-08-08

TAMARIS

P3

Completed

Peripheral Vascular Diseases|Peripheral Arterial Disease

2010-08-01

TALISMAN 211

P2

Completed

Peripheral Arterial Disease|Intermittent Claudication|Arterial Occlusive Diseases

2005-08-01

TALISMAN202

P2

Completed

Peripheral Arterial Disease

2005-07-01

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions